SELLAS Life Sciences (SLS) EPS (Basic) (2020 - 2023)
Historic EPS (Basic) for SELLAS Life Sciences (SLS) over the last 7 years, with Q4 2023 value amounting to -$0.29.
- SELLAS Life Sciences' EPS (Basic) rose 3153.98% to -$0.29 in Q4 2023 from the same period last year, while for Sep 2024 it was -$0.12, marking a year-over-year increase of 9132.03%. This contributed to the annual value of -$1.36 for FY2023, which is 3599.45% up from last year.
- Latest data reveals that SELLAS Life Sciences reported EPS (Basic) of -$0.29 as of Q4 2023, which was up 3153.98% from -$0.33 recorded in Q3 2023.
- SELLAS Life Sciences' EPS (Basic)'s 5-year high stood at -$0.16 during Q1 2021, with a 5-year trough of -$1.05 in Q1 2022.
- In the last 4 years, SELLAS Life Sciences' EPS (Basic) had a median value of -$0.42 in 2021 and averaged -$0.46.
- Its EPS (Basic) has fluctuated over the past 5 years, first skyrocketed by 7575.76% in 2021, then crashed by 55625.0% in 2022.
- Quarter analysis of 4 years shows SELLAS Life Sciences' EPS (Basic) stood at -$0.47 in 2020, then rose by 9.84% to -$0.42 in 2021, then dropped by 2.38% to -$0.43 in 2022, then soared by 31.54% to -$0.29 in 2023.
- Its EPS (Basic) was -$0.29 in Q4 2023, compared to -$0.33 in Q3 2023 and -$0.32 in Q2 2023.